Bone Diseases, Metabolic Recruiting Phase 4 Trials for Velpatasvir (DB11613)

Also known as: Bone Disease, Metabolic

IndicationStatusPhase
DBCOND0028429 (Bone Diseases, Metabolic)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03549312Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patients With HIV-HCV Co-Infected Subjects on Opioid Substitution TherapyTreatment